Conference
A placebo-controlled, randomized phase II study of conatumumab (C) or AMG 479 (A) or placebo (P) plus gemcitabine (G) in patients (pts) with metastatic pancreatic cancer (mPC)
Authors
Kindler HL; Richards DA; Stephenson J; Garbo LE; Lima CSR; Safran H; Wiezorek JS; Feigal EG; Bray S; Fuchs C
Volume
28
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
May 20, 2010
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
15
ISSN
0732-183X